meglumine antimoniate has been researched along with thiazoles in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mesquita, JT; Reimão, JQ; Tempone, AG | 1 |
| Akhoundi, B; Ebrahimzade, E; Elikaee, S; Khalili, S; Mohammadi-Yeganeh, S; Mohebali, M; Moosazadeh Moghaddam, M; Sharifi-Yazdi, MK; Shayan, P | 1 |
2 other study(ies) available for meglumine antimoniate and thiazoles
| Article | Year |
|---|---|
Combination therapy with nitazoxanide and amphotericin B, Glucantime®, miltefosine and sitamaquine against Leishmania (Leishmania) infantum intracellular amastigotes.
Topics: Aminoquinolines; Amphotericin B; Animals; Antiprotozoal Agents; Drug Combinations; Leishmania infantum; Leishmaniasis, Visceral; Macrophages, Peritoneal; Meglumine; Meglumine Antimoniate; Mice; Nitro Compounds; Organometallic Compounds; Parasitic Sensitivity Tests; Phosphorylcholine; Thiazoles | 2014 |
Investigation of the antimicrobial activity of a short cationic peptide against promastigote and amastigote forms of Leishmania major (MHRO/IR/75/ER): An in vitro study.
Topics: Animals; Antimicrobial Cationic Peptides; Antiprotozoal Agents; Coloring Agents; DNA, Protozoan; Dose-Response Relationship, Drug; Inhibitory Concentration 50; Leishmania major; Leishmaniasis, Cutaneous; Macrophages; Meglumine Antimoniate; Mice; RAW 264.7 Cells; Real-Time Polymerase Chain Reaction; Tetrazolium Salts; Thiazoles; Trypan Blue | 2019 |